Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Liebchen

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Epilepsia|June 26, 2025
Optimizing phenobarbital dosing in critically ill patients with refractory and superrefractory status epilepticus using a population pharmacokinetic modelMaximilian Stoschus, Moritz L Schmidbauer, Johannes Starp, et al.
Therapeutic Drug Monitoring|September 16, 2016
Variable Linezolid Exposure in Intensive Care Unit Patients-Possible Role of Drug-Drug InteractionsChristoph Töpper, Cathérine L Steinbach, Christoph Dorn, et al.
Infectious Diseases and Therapy|August 18, 2024
Extracorporeal Elimination of Pro- and Anti-inflammatory Modulators by the Cytokine Adsorber CytoSorb<sup>®</sup> in Patients with Hyperinflammation: A Prospective StudyHelen Graf, Caroline Gräfe, Mathias Bruegel, et al.
Annals of Intensive Care|November 9, 2023
Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective studyAntonia Greimel, Katharina Habler, Caroline Gräfe, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 24, 2021
Comparing posaconazole and itraconazole for antifungal prophylaxis in critically ill lung transplant recipients: Efficacy and plasma concentrationsSimon Kallee, Christina Scharf, Ines Schroeder, et al.
Journal of Personalized Medicine|October 25, 2024
Therapeutic Drug Monitoring of Elexacaftor, Tezacaftor, and Ivacaftor in Adult People with Cystic FibrosisSusanne Naehrig, Christina Shad, Magdalena Breuling, et al.
Antibiotics (Basel, Switzerland)|April 30, 2021
Evaluation of the MeroRisk Calculator, A User-Friendly Tool to Predict the Risk of Meropenem Target Non-Attainment in Critically Ill PatientsUwe Liebchen, Marian Klose, Michael Paal, et al.
Infection|April 25, 2025
Model-informed identification of optimised dosing strategies for meropenem in critically ill patients receiving SLEDD: an observational studyFranz Weber, Christina Scharf, Linda B S Aulin, et al.
International Journal of Antimicrobial Agents|August 15, 2024
Predictive performance of multi-model approaches for model-informed precision dosing of piperacillin in critically ill patientsLea Marie Schatz, Sebastian Greppmair, Alexandra K Kunzelmann, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2023
Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Vancomycin in Patients with External Ventricular DrainZhendong Chen, Max Taubert, Chunli Chen, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Epilepsia|June 26, 2025
Optimizing phenobarbital dosing in critically ill patients with refractory and superrefractory status epilepticus using a population pharmacokinetic modelMaximilian Stoschus, Moritz L Schmidbauer, Johannes Starp, et al.
Therapeutic Drug Monitoring|September 16, 2016
Variable Linezolid Exposure in Intensive Care Unit Patients-Possible Role of Drug-Drug InteractionsChristoph Töpper, Cathérine L Steinbach, Christoph Dorn, et al.
Infectious Diseases and Therapy|August 18, 2024
Extracorporeal Elimination of Pro- and Anti-inflammatory Modulators by the Cytokine Adsorber CytoSorb<sup>®</sup> in Patients with Hyperinflammation: A Prospective StudyHelen Graf, Caroline Gräfe, Mathias Bruegel, et al.
Annals of Intensive Care|November 9, 2023
Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective studyAntonia Greimel, Katharina Habler, Caroline Gräfe, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 24, 2021
Comparing posaconazole and itraconazole for antifungal prophylaxis in critically ill lung transplant recipients: Efficacy and plasma concentrationsSimon Kallee, Christina Scharf, Ines Schroeder, et al.
Journal of Personalized Medicine|October 25, 2024
Therapeutic Drug Monitoring of Elexacaftor, Tezacaftor, and Ivacaftor in Adult People with Cystic FibrosisSusanne Naehrig, Christina Shad, Magdalena Breuling, et al.
Antibiotics (Basel, Switzerland)|April 30, 2021
Evaluation of the MeroRisk Calculator, A User-Friendly Tool to Predict the Risk of Meropenem Target Non-Attainment in Critically Ill PatientsUwe Liebchen, Marian Klose, Michael Paal, et al.
Infection|April 25, 2025
Model-informed identification of optimised dosing strategies for meropenem in critically ill patients receiving SLEDD: an observational studyFranz Weber, Christina Scharf, Linda B S Aulin, et al.
International Journal of Antimicrobial Agents|August 15, 2024
Predictive performance of multi-model approaches for model-informed precision dosing of piperacillin in critically ill patientsLea Marie Schatz, Sebastian Greppmair, Alexandra K Kunzelmann, et al.
Antimicrobial Agents and Chemotherapy|May 10, 2023
Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Vancomycin in Patients with External Ventricular DrainZhendong Chen, Max Taubert, Chunli Chen, et al.
Pageof 7